CUMC Home | Columbia University |
     
 > Home

  Center for Human Genetics Research Bios

Allikmets, Rando

Goldman, Jill

Koval, Carrie

Russo, James J. (Jim)

Vundavalli, Murty

Appelbaum, Paul

Greenberg, David

Lee, Joseph H.

Santella, Regina

Warburton Dorothy

Bank, Arthur Hirano, Michio Levy, Brynn Schon, Eric Weissman, Myrna

Chung, Wendy

Hodge, Susan  E.

Marder, Karen

Schupf, Nicole

Williamson Catania, Jennifer

Fraser, Janice

Jobanputra, Vaidehi

Mayeux, Richard

Spitalnik, Steven

 

Frucht, Harold

Karayiorgou, Maria

Ottman, Ruth

Terry, Mary Beth

 

Gharavi, Ali

Karsenty, Gerard

Pirzadeh, Sara

Tsang, Stephen

 

 

   
Researcher Biographical Page

Last name

Allikmets

First name

Rando

Credentials

PhD

Title

Acquavella Associate Professor of Ophthalmology (in Ophthalmology and Pathology & Cell Biology)
Research Director, Dept of Ophthalmology and Harkness Eye Institute

Location of your lab

Eye Institute Research
7th Floor, Room 715
160 Fort Washington Avenue

New York, NY 10032

Location of your clinic

URL of your lab home page:

Researcher picture and lab art:

Rando Allikmets

Research Theme and Projects in your lab:

Genetic cause of Stargardt macular dystrophy and other retinal diseases

ABC transporter superfamily

Association analysis of genetic variation in candidate genes for complex disorders e.g., age-related macular generation

Development of microarray based screening technologies
New approaches for ABC gene therapy.

If you see patients, in which clinic do you attend

Patients are enrolled into our studies at the Harkness Eye Institute

Education and Training Programs to which you belong

Integrated Program
Vision Science Training Grant

Bullet List of Genetic Diseases on which you work:

Age-related macular degeneration
Stargardt diseases
Retinitis pigmentosa
Leber congenital amaurosis
Other retinal diseases

Six Selected Publications (2003-present):

Lamba, J.K., Adachi, M., Sun, D., Tammur, J., Schuetz, E.G., Allikmets, R., and Schuetz, J. Nonsense mediated decay down-regulates conserved alternatively spliced ABCC4 transcript bearing nonsense codons. Hum. Mol. Genet.12:99-109, 2003.

Jaakson, K., Zernant, J., Külm, M., Hutchinson, A., Tonisson, N, Hawlina, M., Ravnic-Glavac, M., Glavac, D., Meltzer, M., Caruso, R., Testa, F., Maugeri, A., Hoyng, C.B., Gouras, P., Simonelli, F., Lewis, R.A. Lupski, J.R., Cremers, F.P.M., and Allikmets, R. Genotyping microarray (gene chip) for the ABCR (ABCA4) gene. Hum. Mutat., 22:395-403, 2003.

Kim, S.R., Fishkin, N., Kong, J., Nakanishi, K., Allikmets, R., and Sparrow, J.R. Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E. Proc. Natl. Acad. Sci. USA, 101:11668-11672, 2004.

Hageman, G.S., Anderson, D.H., Johnson, L.V., Hancox, L.S., Taiber, A.J., Hardisty, L.I., Hageman, J.L., Stockman, H.A., Borchardt, J.D., Gehrs, K.M., Smith, R.J., Silvestri, G., Russell, S.R., Klaver, C.C.W., Barbazetto, I., Chang, S., Yannuzzi, L.A., Barile, G.R., Merriam, J.C., Smith, R.T., Olsh, A.K., Bergeron, J., Zernant, J., Merriam, J.E., Gold, B., Dean, M. and Allikmets R.  A common haplotype in the complement regulatory gene, factor H (HF1/CFH), predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA, 102:7227-7232, 2005.

Maiti, P., Kong, J., Kim, S.R., Sparrow, J.R., Allikmets, R., and Rando, R.R. Small Molecule RPE65 Antagonists Limit the Visual Cycle and Prevent Lipofuscin Formation. Biochemistry, 45:852-860, 2006.

Gold, B., Merriam, J.E., Zernant, J., Hancox, L.S., Taiber, A.J., Gehrs, K.M., Cramer, K., Neel, J., Bergeron, J., Barile, G.R., Smith, R.T., the AMD Genetics Clinical Study Group, Hageman, G.S., Dean, M. and Allikmets R.  Variation in the Factor B (BF) and Complement Component 2 (C2) Genes is Associated with Age-related Macular Degeneration. Nature Genet., 38:458-462, 2006


|Top|


Researcher Biographical Page

Last name

Appelbaum

First name

Paul

Credentials

MD

Title

Professor and Director, Division of Psychiatry, Law and Ethics, Department of Psychiatry

Location of your lab
Location of your clinic
URL of your lab home page:

Rm. 6707, NY State Psychiatric Institute

Researcher picture and lab art:

Sent.

Research Theme and Projects in your lab:

Ethical and legal aspects of genetic research and interventions, including informed consent, competence to consent to research and treatment, confidentiality of genetic information, screening for genetic disorders, use of genetic information in legal settings (e.g., claims of reduced culpability because of genetic propensities to engage in criminal behavior).

If you see patients, in which clinic do you attend

Dept. of Psychiatry Faculty Practice
Contact Dr. Appelbaum at 212-543-4184

Education and Training Programs to which you belong

Adult Psychiatry Residency Training
Forensic Psychiatry Fellowship Program

Bullet List of Genetic Diseases on which you work:

Particular interest in behavioral genetics and the genetics of psychiatric and neurological disorders. But interested in ethical and legal issues in all genetic diseases.

Six Selected Publications (2003-present):

Appelbaum PS:  Ethical issues in psychiatric genetics.  Journal of Psychiatric Practice 2004; 10:343-351
Appelbaum PS: Behavioral genetics and the punishment of crime.  Psychiatric Services 2005; 56:25-27
Hoge SK, Appelbaum PS:  Ethical, legal, and social implications of psychiatric genetics and genetic counseling, in Tsuang MT, Smoller JW, Rosen-Sheidley B (eds.):  Psychiatric Genetics:  Applications in Clinical Practice.  American Psychiatric Publishing, Arlington, VA (in press).
Appelbaum PS, Lidz, C:  The therapeutic misconception, in Emanuel EJ, Crouch RA, Grady C, Lie R, Miller F, Wendler D (eds.), The Oxford Textbook of Clinical Research Ethics.  New York, Oxford University Press (in press).
Appelbaum PS, Grisso T:  The MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR).  Professional Resource Press, Sarasota, FL, 2001
Berg JW, Appelbaum PS, Lidz CW, Parker L:  Informed Consent:  Legal Theory and Clinical Practice, 2nd edition.  Oxford University Press, New York NY, 2001.

|Top|

Researcher Biographical Page

Last name

Bank

First name

Arthur

Credentials

M.D.

Title

Professor Emeritus of Medicine and of Genetics and Development

Location of your lab
Location of your clinic
URL of your lab home page:

HHSC 1612

Researcher picture and lab art:

Research Theme and Projects in your lab:

The laboratory is funded to develop new methods to do gene therapy for beta thalassemia and sickle cell anemia. This research includes developing new stable packaging lines to do lentiviral globin gene therapy. I am also a co-investigator in an ongoing clinical trial of globin gene therapy underway in Paris, France as part of the sponsor of the trial, Genetix Pharmaceuticals, Inc.
The laboratory is also working on the role of the transcription factors Ikaros and Notch in hematopoiesis.

If you see patients, in which clinic do you attend

Education and Training Programs to which you belong

Bullet List of Genetic Diseases on which you work:

Thalassemia, sickle cell anemia

Six Selected Publications (2003-present):

Ward, M., Sattler, R., Grossman, I. R., Bell, A. J., Skerrett, D., Baxi, L., and Bank, A.  A stable murine-based RD114 retroviral packaging line efficiently transduces human hematopoietic cells. Molecular Therapy, 8:804-812, 2003.

Bank, A., Dorazio, R. and Leboulch, P. A Phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia. Annals NY Acad Sciences, 1054:308-316,2005.

Bank, A. Understanding globin regulation in beta thalssemia: it’s as simple as alpha, beta, gamma, delta. J. Clin. Invest., 115:1470-3. 2005.

Pulte, D., Lopez, R.A., Baker, S.T., Ward, M., Ritchie, E., Richardson, C.A.’ O’Neill, D.W., and Bank, A. Ikaros increases normal apoptosis in adult erythroid cells. American  J. Hematology, 81:12-18, 2006.

Bank, A. Regulation of human fetal hemoglobin: new players, new complexitites. Blood, 107: 435-43, 2006.

Mantha, S., Ward, M., McCafferty, J., Herron, A., Palomero, T., Ferrando, A., Bank, A., Richardson, C. Activating Notch 1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice. Leuk. Res, 2006.

|Top|

Researcher Biographical Page

Last name

Chung

First name

Wendy

Credentials

MD PhD

Title

Herbert Irving Assistant Professor of Pediatrics and Medicine, Director of Clinical Genetic
Director of the Cytogenetics/Molecular Genetics Fellowship

Location of your lab

1150 St Nicholas Avenue, Room 620

Location of your clinic

Babies Hospital 6 North, 601
Irving Pavilion 1028

URL of your lab home page:

http://www.cumc.columbia.edu/dept/pediatrics/molec/molec.html

Researcher picture and lab art:

Chung, Wendy

Research Theme and Projects in your lab:

A major focus of our research is in the molecular genetics of obesity in humans with increased emphasis on computational analysis of gene by gene interactions. As part of the project we recently created a mouse carrying a human gene variant in the leptin receptor that has been associated with excess body fat. We are studying the ingestive behavior and energy expenditure of this mouse. A second project is designed to clone modifier genes for type 2 diabetes from obese mice. We have identified a candidate gene of unknown function whose hypoactivity causes reduced beta cell mass. The molecular physiology of this gene is being pursued in a knockout mice.

As the molecular genetics core laboratory for studies in the Pediatric Heart Network, we are identifying genetic factors modulating disease severity of congenital heart disease.  We are also studying genetic polymorphisms that determine the rate of progression for cardiomyopathy and pulmonary hypertension. We are characterizing the genetic causes of cardiomyopathy and arrhythmias and are developing novel methods of high throughput screening for gene panels.  We are clinically and genomically characterizing children with congenital heart disease and congenital diaphragmatic hernias for copy number changes in the germline. 

As the molecular genetics core for the Pediatric Neuromuscular Clinical Research Network, we work with an established clinical research network that clinically and molecularly characterizes patients with spinal muscular atrophy and is preparating for SMA clinical trials.

We are identifying novel genes for breast cancer susceptibility through the Breast Cancer Family Registry and attempting to identify genetic modifiers of the breast cancer susceptibility genes BRCA1 or BRCA2.

If you see patients, in which clinic do you attend

Pediatrics
Prenatal
Cardiovascular Genetics
Muscular dystrophy clinic
Cancer genetics
Von Hippel Lindau
Cystic fibrosis
Vascular anomalies
212-305-6731
See website for further details http://www.cumc.columbia.edu/dept/pediatrics/clin/intro.html

Education and Training Programs to which you belong

Cardiovascular Development and Disease in the Young
Multidisciplinary Training in Translational Cardiovascular Research
Training Grant in Neonatal-Perinatal Medicine
Training Grant in Pharmacological Sciences
MD/PhD Training Grant
Director of the Cytogenetics and Molecular Genetics Fellowship
Faculty member for the Medical Genetics Residency
Section chief, Genetics for SBMP medical student course

Bullet List of Genetic Diseases on which you work:

Obesity
Diabetes
Cardiomyopathies
Congenital heart disease
Arrhythmias
Breast cancer
Spinal muscular atrophy
Birth defects
Congenital diaphragmatic hernias

Six Selected Publications (2003-present):

Jobanputra V, Sebat J, Troge J, Chung W, Anyane-Yeboa K, Wigler M, Warburton D.  Application of ROMA (representational oligonucleotide microarray analysis) to patients with cytogenetic rearrangements. Genet Med. 2005 Feb;7(2):111-8.

Sun, L., Eklund, E. A., Chung. W. K., Cohen, J., and Freeze. H.,  Congenital Disorder of Glycosylation Id (CDG-Id) Presenting with Hyperinsulinemic Hypoglycemia and Islet Cell Hyperplasia. J Clin Endocrinol Metab. 90(7):4371-5, 2005.

Matsuoka, N., Patki, A., Tiwari, H.K., Allison, D.B., Johnson, S.B., Gregersen, P.K.,Leibel, R.L., and Chung, W.K. Association of K121Q Polymorphism in ENPP1 (PC-1) with BMI in Caucasian and African-American Adults.  International Journal of Obesity. Oct 11 2005.

Codner, E., Deng, L., Pérez-Bravo, F., Román, R., Lanzano, P.,

Cassorla, F., and  Chung, W.K., Glucokinase mutations in young children with hyperglycemia.  Diabetes and Metabolism Research and Reviews.  Jan 30 2006; Epub.

Phan, L. K., Chung, W. K., Leibel, R. L., The Mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independent of effects on adiposity.  American Journal of Physiology.  In press.

Tierney, E. S., Marans, Z, Rutkin, M.B. , Chung, W.K. CRYPTIC (CFC1) Variants in Laterality Defects Associated with Congenital Heart Disease.  Cardiology in the Young, Accepted. 

|Top|

Researcher Biographical Page

Last name

Fraser

First name

Janice

Credentials

MS, CGC

Title

Genetic Counselor/Research Coordinator

Location of your lab

Location of your clinic

Neurological Institute, 3rd floor

URL of your lab home page:

http://www.movement-disorders.org/genetic.html

Researcher picture and lab art:

Research Theme and Projects in your lab:

Genetics of Movement Disorders
Consortium On Risk for Early-onset PD (COREPD)
Beta-glucocerebrosidase mutations and PD in the Ashkenazim

If you see patients, in which clinic do you attend

Movement Disorders, Neurological Institute 3rd floor

Education and Training Programs to which you belong

Bullet List of Genetic Diseases on which you work:

Parkinson’s Disease
Dystonias
Spinocerebellar Ataxias

Six Selected Publications (2003-present):

|Top|

Researcher Biographical Page

Last name

Frucht

First name

Harold

Credentials

MD

Title

Associate Professor of Clinical Medicine

Location of your lab

Location of your clinic

Herbert Irving (Atchley) Pavilion, Suite #301

URL of your lab home page:

http://www.columbiasurgery.org/pat/pancreas/prevention.html
http://www.cumc.columbia.edu/dept/gi/colonca.html

Researcher picture and lab art:

Research Theme and Projects in your lab:

Syndromic Gastrointestinal Cancers:

Genetic counseling & testing, risk-stratification, and early detection & prevention of gastrointestinal cancers including colon cancer and pancreas cancer.

If you see patients, in which clinic do you attend

Gastrointestinal High Risk/Genetics/Screening Program
Digestive Diseases Division Clinical Office
(212) 305-1021 or (212) 305-5333

Education and Training Programs to which you belong

As above

Bullet List of Genetic Diseases on which you work:

- familial polyposis coli (175100, 276300)
- familial juvenile polyposis (174900)
- hereditary non-polyposis colon cancer (120435, 609310, 158320, 114400, 13725)
- familial pancreatic cancer (260350)
- familial atypical multiple melanoma mole syndrome (606719)
- peutz-jeghers syndrome (175200)
- hereditary pancreatitis (167800)
- BRCA syndrome (113705, 600185)
- multiple endocrine neoplasia type I syndrome (131100)

Six Selected Publications (2003-present):

Calvert P, Frucht H. The genetics of colorectal cancer. Annals of Internal Medicine. 2002; 137:603-612.

Frucht H, Stevens PD, Fogelman DR, Verna EC, Chen J, Chabot JA, Fine RL. Advances in the Genetic Screening, Work-up, and Treatment of Pancreatic Cancer. Current Treatment Options in Gastroenterology.  2004; 7:343-354.


|Top|

Researcher Biographical Page

Last name

Gharavi

First name

Ali

Credentials

1986:  B.S. Georgetown Univ.
1990: M.D. George Washington Univ.
1990-93: Intern and Resident in Medicine, Mount Sinai Medical CenterNew York, NY
1996-98: Fellow in Nephrology, Mount Sinai Medical Center, NY
1997-2002 : Yale University, Post Doc in Genetics

Title

Assistant Professor of Medicine

Location of your lab

P&S 10-432

Location of your clinic

URL of your lab home page:

Researcher picture and lab art:

Research Theme and Projects in your lab:

End-stage renal disease requiring dialysis therapy affects one in a seven hundred Americans. The molecular bases of renal failure are largely unknown but multiple lines of evidence suggest that genetic susceptibility is an important causative factor.  We are interested in several disorders that  result in renal failure:

1- IgA nephropathy (IgAN, OMIM #161950) is the most common form of glomerulonephritis and a significant cause of renal failure worldwide.  This trait has complex determination.  Starting with a collection of kindreds with familial disease, we have mapped the first locus for IgA nephropathy to chromosome 6q22-23 and our efforts are now geared towards identifying the underlying genes using approaches such as disequilibrium mapping and sequencing of positional candidates. In addition, mapping projects in newer families and case-control cohort recruited worldwide are expected to identify additional loci and variants responsible for IgA nephropathy.

2- Nonsyndromic defects in the urinary tract are the most common cause of end-stage renal failure in children. Renal agenesis (OMIM %191830) is one of the most severe forms of malformations and is also commonly accompanied by anatomic abnormalities in the lower urinary tract such as ureteropelvic junction (UPJ) obstruction or vesicoureteral reflux (VUR %193000).  The genetic basis of these disorders is not known.  We are studying cohorts segregating renal agenesis or VUR in order to identify genes and variants predisposing to these traits.

If you see patients, in which clinic do you attend

Nephrology
212-305-0320

Education and Training Programs to which you belong

Cardiology training program, Columbia University
Nephrology Training program (Mt Sinai School of Medicine)

Bullet List of Genetic Diseases on which you work:

  • IgA nephropathy
  • HIV nephropathy
  • Vesicoureteral Reflux
  • Renal agenesis and Renal Developmental Defects

Six Selected Publications (2003-present):

1. Gharavi AG, Ahmad T, Wong RD, Hooshyar R, Vaughn J, Oller S, Frankel RZ , Bruggeman LA , D'Agati VD , Klotman PE , and Lifton RP. Mapping a Locus (HIVAN1) for Susceptibility to HIV-1 Associated Nephropathy to Mouse Chromosome 3. Proc Natl Acad Sci U S A.  2004, 101:2488-2493

2. Davila S., Furu L., Gharavi AG, Tian X., Onoe T., Qian Q, Li A., Kamath PS, King BF, Azurmendi PJ, Tahvanainen, Kääriäinen H, Höckerstedt K, Devuyst O, Pirson Y, Martin R, Lifton R, Tahvanainen E, Torres V, Somlo S. Mutations in SEC63 cause autosomal dominant polycystic liver disease and implicate posttranslational modification pathways in epithelial cyst formation. Nat. Genetics 2004, 36:575-7

3. Zheng Z,  Ott-Schmitt K, Chua S., Foster K A., Frankel R Z., Barasch J,  Pavlidis P., D’ Agati VD, Gharavi AG.  A Mendelian Locus on Chromosome 16 Determines Susceptibility to Doxorubicin Nephropathy In The Mouse. Proc Natl Acad Sci U S A.  2005;102:2502-2507

4. Sanna-Cherchi S, Reese A, Hensle T, Caridi G, Izzi C, KimYY, Murer L, Scolari F, Ravazzolo R, Ghiggeri GM, Gharavi AG.  Familial Vesicoureteral Reflux:  Testing Replication of Linkage in Seven New Multigenerational Kindreds.  J Am Soc Nephrol 2005;16:1781-7

5. C Izzi, S Sanna-Cherchi, E Prati, D Beller , A Remedi , R Tardanic , M Foramitt , S Guerini, B Viol , G Brunori, E Movilli, I Beerman, R Lifton, P Paterlini, C Della Torre, L Leone, Gharavi AG, Scolari F. Familial Aggregation of Primary Glomerulonephritis in an Italian Population Isolate: the Valtrompia Study. Kidney International 2006 69:1033-40


|Top|

Researcher Biographical Page

Last name

Greenberg

First name

David A.

Credentials

Ph.D., Physiology and Biochemistry, Washington University, St. Louis, MO, 1976

Title

Director, Division of Statistical Genetics; Professor, Departments of Biostatistics and Psychiatry;

Location of your lab

(Office) 722 West 168th Street, Room 623

Location of your clinic

URL of your lab home page:

“Division of Statistical Genetics” Web page is currently being developed.

Researcher picture and lab art:

David Greenberg

Research Theme and Projects in your lab:

“A Multicenter Study of Idiopathic Generalized Epilepsy”
This grant has four goals: 1) Determine the sequence differences in the malic enzyme 2 gene (ME2) that cause the association of ME2 with idiopathic generalized epilepsy. 2) Locate the genes within the areas of high linkage on chromosomes 5 and 8. 3) Determine if the ME2 and BRD2 genes, both of which are associated with JME, interact. 4) Determine whether the associations we have identified in the Caucasian population can also be found in the African American and Hispanic populations. The last aim is critical for understanding how the causes of IGE may differ in different ethnic groups.
Principal Investigator: David A. Greenberg
.Agency: NIH-NINDS
Type: RO1 NS027941. Years 17 – 21.
Period: 8/15/2006 – 1/31/2011

“Two-Locus Models, Heterogeneity and Diabetes”
The major goal of this project is to use computer simulation to investigate problems in the analysis of human genetic data and develop new analysis methods.
Principal Investigator: David A. Greenberg
Agency: NIH-NIDDK
Type RO1 DK031775, Years 20 – 24.
Period: April 1, 2003 – February 28, 2007

“Search for Genes Influencing Childhood Absence Epilepsy”
The major goal of this project is performing genome screens on childhood absence families.
Principal Investigator: Martina Durner
Agency: NIH –NINDS
Type: RO1 NS037466, Years 1-5.
Period: June 1, 2006 to May 31, 2011.

“Genetics of Rolandic Epilepsy”
The goal is to find the susceptibility genes underlying rolandic epilepsy and its component EEG and neurodevelopmental traits.
Principal Investigator – Deb Pal, M.D.
Agency:NIH-NINDS
Type: RO1 NS047530-01
Period: January 15, 2005 to January 14, 2009

“Mapping Autoimmune Diabetes and Thyroiditis Genes”
The goal is to determine genes common to expression of Type 1 Diabetes and Autoimmune Thyroid Disease.
Subcontract from University of Cincinnati, Principal Investigator – David A. Greenberg, Ph.D.
Agency NIH
Type: DK067555-01A1
Period: January 31, 2005 to January 30, 2009

“Schizophrenia Premorbid Endophenotype”
The major goal of this project is to investigate the inheritance of schizophrenia
Subcontract from Mt. Sinai Medical Center,
.Principal Investigator – David A. Greenberg, Ph.D.
Agency NIH/NIMH –
Type: RO1 MH066105
Period: March 1, 2006 – February 28, 2009

If you see patients, in which clinic do you attend

Education and Training Programs to which you belong

Co-Principal Investigator on “Genetic Analysis: Psychiatric and Other Complex Diseases,” The Genetics of Complex Disorders (GCD) training program.  NIMH T32 Training Grant, 2002–2007 (renewal submitted).

Co-director of Division of Statistical Genetics, in Dept. of Biostatistics, School of Public Health (Dr. David A. Greenberg, Director).

Also supervise the new Master’s track in Statistical Genetics, in Dept. of Biostatistics, School of Public Health.

Mathematical Genetics Unit in Dept. of Psychiatry (in Dr. Myrna Weissman’s Clinical-Genetic Epidemiology Unit)

Bullet List of Genetic Diseases on which you work:

  • Idiopathic Generalized Epilepsy
  • Autoimmune Thyroid Disease
  • Schizophrenia
  • Diabetes

Six Selected Publications (2003-present):

Greenberg DA, Durner, M, Keddache, M, Shinnar et al (2000) Reproduceability and Complications in Gene Searches: Linkage, Heterogeneity, Association, and Inheritance in Juvenile Myoclonic Epilepsy. Am J Hum Genet 66:508-516.

Durner M, Keddache M, Shinnar SS, Resor SR, Cohen J, Harden C, Moshe S.L, Rosenbaum D, Kang H, Ballaban-Gil K, Hertz S, Labar DR, Luciano D, Wallace S, Yohai D, Klotz I, Dicker E, Greenberg DA (2001): Genome scan of idiopathic Generalized epilepsy: Evidence for major susceptibility gene and modifying genes influencing seizure type. Annals of Neurology.49:328-335.

Greenberg DA, Abreu P (2001): Determining trait locus position from multipoint analysis: accuracy and power of three different statistics. Genetic Epidemiology 21:299-314.

Pal DK, Evgrafov OV, Tabares P, Zhang F, Durner M, Greenberg DA (2003): BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy. Am J Hum Genet. 73:261-70.

Heiman G, Hodge S.E, Goroochurn P, Zhang J, Greenberg DA (2004): Effect of population stratification on case- control association studies: I. Elevation in false positive rates and comparison to confounding risk ratios (a simulation study). Hum Hered. 58:30-39.

Greenberg DA, Cayanis E, Strug,et al (2005): Malic Enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy. Am J Hum Genet. 76:139–146


|Top|

Researcher Biographical Page

Last name

Goldman

First name

Jill

Credentials

MS, MPhil, CGC

Title

Senior Staff Associate, Genetic Counselor

Location of your lab

Sergievsky Center, Taub Institute

Location of your clinic

630 W. 168th St, 19th floor

URL of your lab home page:

http://www.alzheimercenter.org

Researcher picture and lab art:

Goldman Jill

Research Theme and Projects in your lab:

If you see patients, in which clinic do you attend

We see patients who are at risk for hereditary dementia including, Alzheimer disease, Huntington disease, Frontotemporal dementia, Prion disease.
Patients should contact me at 212-305-7382

Education and Training Programs to which you belong

Bullet List of Genetic Diseases on which you work:

Alzheimer disease
Frontotemporal dementia and related diseases
Prion disease
Other hereditary dementias such as CADASIL

Six Selected Publications (2003-present):

Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, Lomen-Hoerth C, Wilhelmsen KC, Lee VM, Grossman M, Miller BL. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005 Dec 13;65(11):1817-9

Goldman JS, Johnson JK, McElligott K, Suchowersky O, Miller BL, Van Deerlin VM. Presenilin 1 Glu318Gly polymorphism: interpret with caution. Arch Neurol. 2005 Oct;62(10):1624-7.

Goldman JS, Farmer JM, Van Deerlin VM, Wilhelmsen KC, Miller BL, Grossman M. Frontotemporal dementia: genetics and genetic counseling dilemmas. Neurologist. 2004 Sep;10(5):227-34.

Goldman JS, Miller BL, Safar J, de Tourreil S, Martindale JL, Prusiner SB, Geschwind MD. When sporadic disease is not sporadic: the potential for genetic etiology. Arch Neurol. 2004 Feb;61(2):213-6.

Goldman JS, Reed B, Gearhart R, Kramer JH, Miller BL. Very early-onset familial Alzheimer's disease: a novel presenilin 1 mutation. Int J Geriatr Psychiatry. 2002 Jul;17(7):649-5.

Wilhelmsen KC, Forman MS, Rosen HJ, Alving LI, Goldman J, Feiger J, Lee JV, Segall SK, Kramer JH, Lomen-Hoerth C, Rankin KP, Johnson J, Feiler HS, Weiner MW, Lee VM, Trojanowski JQ, Miller BL. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.
Arch Neurol. 2004 Mar;61(3):398-406.

|Top|

Researcher Biographical Page

Last name

Hirano

First name

Michio

Credentials

MD
Adult neurologist

Title

Associate Professor

Location of your lab

P&S 4-443

Location of your clinic

Neurological Institute of New York, 9th Floor

URL of your lab home page:

Researcher picture and lab art:

Research Theme and Projects in your lab:

My laboratory is part of the H. Houston Merritt Clinical Research Center. We study neuromuscular and mitochondrial diseases. We have identified causative genes for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), Danon disease, and coenzyme Q10 deficiency. We are exploring the pathogenesis and treatments for MNGIE and coenzyme Q10 deficiency and hunting for genes causing scapuloperoneal muscular dystrophy and limb-girdle muscular dystrophy 1F.

If you see patients, in which clinic do you attend

Dr. Hirano is the Co-Director of the Muscular Dystrophy Association Clinic at Columbia University.

Education and Training Programs to which you belong

Bullet List of Genetic Diseases on which you work:

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), OMIM 603041
Coenzyme Q10 deficiency, OMIM 607426
Scapuloperoneal muscular dystrophy, OMIM 181430
Limb girdle muscular dystrophy 1F, OMIM 608423

Six Selected Publications (2003-present):

Nishigaki Y, Martí R, Copeland WC, Hirano M (2003) Site-specific mtDNA point mutations due to thymidine phosphorylase deficiency. J Clin Invest 111:1913-1921

Palenzuela L, Andreu AL, Gamez J, Vilà MR, Kunimatsu T, Meseguer A, Cervera C, Fernandez Cadenas I, Van Der Ven PF, Nygaard TG, Bonilla E, Hirano M (2003) A novel autosomal dominant limb-girdle muscular dystrophy (LGMD 1F) maps to 7q32.1-32.2. Neurology 61:404-406

Quinzii CM, Kattah AG, Naini A, Akman HO, Mootha VK, DiMauro S, Hirano M (2005) Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64:539-541

Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, DiMauro S, Hirano M (2006) A Mutation in Para-Hydroxybenzoate-Polyprenyl Transferase (COQ2) Causes Primary Coenzyme Q10 Deficiency. Am J Hum Genet 78:345-349

Karadimas CL, Vu TH, Holve SA, Chronopoulou P, Quinzii C, Johnsen SD, Kurth J, Eggers E, Palenzuela L, Tanji K, Bonilla E, De Vivo DC, DiMauro S, Hirano M (2006) Navajo Neurohepatopathy Is Caused by a Mutation in the MPV17 Gene. Am J Hum Genet 79:544-548

Hirano M, Martí R, Casali C, Tadesse S, Uldrick T, Fine B, Escolar DM, Valentino ML, Nishino I, Hesdorffer C, Schwartz J, Hawks RG, Martone DL, Cairo MS, DiMauro S, Stanzani M, Garvin JH, Savage DG (2006) Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology in press

|Top|

Researcher Biographical Page

Last name

Hodge

First name

Susan  E.

Credentials

D.Sc., Applied Mathematics & Computer Science, Washington University, St. Louis, MO, 1976.

Title

Professor of Clinical Biostatistics (in Psychiatry)

Location of your lab

Location of your clinic

Office: Room 117, Kolb Annex of NYSPI (NY State Psychiatric Institute)

URL of your lab home page:

“Division of Statistical Genetics” Web page is currently being developed.

Researcher picture and lab art:

Susan Hodge

Research Theme and Projects in your lab:

Statistical methodology in genetic epidemiology; also mathematical modeling.  Examples: methods of linkage analysis; methods of association analysis; dealing with population stratification in association analysis; testing for and incorporating genetic heterogeneity; issues of “multiple testing”;  etc.
Current research grants on which Dr. Hodge is P.I.:
“Linkage and Association in Complex Genetic Diseases.”  NIH, 1983–2008.
“Psychiatric Genetics and Family Studies: Robust Methods.”  NIMH, 1992–2010.

If you see patients, in which clinic do you attend

Education and Training Programs to which you belong

Principal Investigator on “Genetic Analysis: Psychiatric and Other Complex Diseases,” The Genetics of Complex Disorders (GCD) training program.  NIMH T32 Training Grant, 2002–2007 (renewal submitted).

Co-director of Division of Statistical Genetics, in Dept. of Biostatistics, School of Public Health(Dr. David A. Greenberg, Director).

Also supervise the new Master’s track in Statistical Genetics, in Dept. of Biostatistics, School of Public Health.

Mathematical Genetics Unit in Dept. of Psychiatry (in Dr. Myrna Weissman’s Clinical-Genetic Epidemiology Unit)

Member of PET (Psychiatic Epi Training program)

Bullet List of Genetic Diseases on which you work:

Panic disorder
A genetic study of fear and anxiety

Six Selected Publications (2003-present):

Hamilton, S.P., Fyer, A.J., Durner, M., Heiman, G.A., de Leon, A.B., Hodge, S.E., Knowles, J.A. & Weissman, M.M. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. PNAS 100: 2550–2555, 2003.

Spence, M.A., Greenberg, D.A., Hodge, S.E. & Vieland, V.J. The Emperor’s new methods. Invited Editorial. Am J Hum Genet 72: 1084–1087, 2003.

Lindholm, E., Zhang, J., Hodge, S.E. & Greenberg, D.A. The reliability of haplotyping inference in nuclear families: Misassignment rates for SNPs and microsatellites.  Hum Hered 57: 117–127, 2004.

Heiman, G.A., Hodge, S.E., Gorroochurn, P., Zhang, J. & Greenberg, D.A. Effect of population stratification on false positive rates in association analysis. I. Elevation in false positive rates and comparison to confounding risk ratios (a simulation study). Hum Hered 58:30–39, 2004.

Gorroochurn, P., Hodge, S.E., Heiman, G. & Greenberg, D.A. Effect of population stratification on case-control association studies. II. False-positive rates and their limiting behavior as the number of subpopulations increases. Hum Hered 58: 40–48, 2004.

Strug, L.J & Hodge, S.E. An alternative foundation for the planning and evaluation of linkage analysis. I. Decoupling “error probabilities” from “measures of evidence.” Hum Hered 61: 166–188, 2006.

Strug, L.J. & Hodge, S.E. An alternative foundation for the planning and evaluation of linkage analysis. II. Implications for multiple test adjustments. Hum Hered, in press.

|Top|

Researcher Biographical Page

Last name

Jobanputra

First name

Vaidehi

Credentials

Ph.D. ABMG certified in Clinical Cytogenetics

Title

Assistant Professor of Clinical Pathology

Location of your lab

Cytogenetics Laboratory, CHC - 406

Location of your clinic

vj2004@columbia.edu

Researcher picture and lab art:

Vaidehi Jobanputra

Research Theme and Projects in your lab:

I am interested in studying constitutional chromosomal disorders. In collaboration with Dorothy Warburton and the Wigler Lab at Cold Spring Harbor Laboratory we have previously demonstrated the accuracy and sensitivity of ROMA (Representational Oligonucleotide Microarray Analysis) to describe copy number changes in patients with known chromosomal abnormalities. This analysis has served to illustrate the resolution with which we can define chromosomal imbalances. We are now applying this approach to study genomic copy number changes in children with congenital heart defects.

More recently with Brynn Levy we are accessing the utility of SOMA (SNP Oligonucleotide Microarray Analysis) for clinical cytogenetic diagnosis. We are analyzing copy number changes in patients with previously known and unknown constitutional structural chromosome rearrangements. This information should immensely improve our ability both to understand the mechanisms of chromosomal rearrangements and to provide more accurate prognosis both prenatally and postnatally to parents of offspring with chromosomal aberrations.

Another focus of our research is to understand the factors contributing to nondisjunction in ageing human oocytes. Advanced maternal age is the only established risk factor for trisomy, the most frequent known cause of embryonic death and a major cause of severe mental retardation. Genetic studies suggest that the error arises principally during meiosis I of the oocyte both for trisomy 21 births (Down syndrome) and for trisomies among spontaneous abortions. We are studying meiotic proteins affecting chromosome segregation in oocytes from women of different age groups.

If you see patients, in which clinic do you attend

Division of Clinical Genetics, Department of Pediatrics.

Education and Training Programs to which you belong

ABMG training program in Clinical Cytogenetics and Molecular Genetics.

Bullet List of Genetic Diseases on which you work:

Constitutional chromosomal disorders
Congenital Heart Disease

Six Selected Publications (2003-present):

1. Jobanputra V, Sobrino A, Kinney A, Kline J, Warburton D. Multiplex interphase FISH as a screen for common aneuploidies in spontaneous abortions. Hum Reprod (2002) 17(5):1166-1170.

2. Jobanputra V, Sebat J, Troge J , Chung W, Yeboa KA, Wigler M, Warburton D. Application of ROMA (Representational oligonucleotide Microarray Analysis) to Patients with Cytogenetic Rearrangements. Genetics In Medicine (2005) 7(2) 111-118.

3. Jobanputra V, Chung W, Hacker A.M., Emanuel B.S., Warburton D. A unique case of der(11)t(11;22),-22 arising from 3:1 segregation of a maternal t(11;22) in a family with co-segregation of the translocation and breast cancer. Prenatal Diagnosis (2005) 25(8):683-686.

|Top|

Researcher Biographical Page

Last name

Karayiorgou

First name

Maria

Credentials

M.D.

Title

Professor

Location of your lab

1051 Riverside Drive, Room 5917

Location of your clinic

URL of your lab home page:

Under construction

Researcher picture and lab art:

Research Theme and Projects in your lab:

My laboratory works on the genetic causes of major psychiatric illness. Our main focus is on schizophrenia (SCZ), a complex psychiatric disorder that affects ~1% of the population world-wide. Our research is multi-faceted and utilizes a number of cutting-edge technologies, including genome-wide association studies, generation of sophisticated genetic mouse models and evaluation of quantitative phenotypes in patients.

Our current active projects include:

1. Identification of SCZ-susceptibility genetic loci through linkage and genome-wide association studies in an exclusive sample of multiplex families we have collected from the genetically isolated Afrikaner population. In this sample, in collaboration with Dr. Abecasis at Michigan, we have already identified strong disease susceptibility loci on chromosomes 1 and 13, which we have fine-mapped through extensive SNP genotyping to a few kilobases candidate intervals. Our current efforts focus on further fine-mapping and re-sequencing of resident genes for identification of disease-associated variants.

2. Detailed studies of biological function of risk haplotypes and risk genetic variants identified in SCZ patients, as well as generation and evaluation of reliable animal models for strong susceptibility genes identified directly through